Status:
COMPLETED
Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer
Lead Sponsor:
University Hospital, Gasthuisberg
Conditions:
Liver Neoplasms
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Microwave ablation (MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate the variability and reproducibility of single-probe MWA versus r...
Eligibility Criteria
Inclusion
- Unresectable metastatic liver cancer
- No invasion of major biliary structures
- No invasion of major vascular structures
- ASA score \< 4
- WHO score 0-1
- Pre-operative chemotherapy is allowed
Exclusion
- Resectable liver metastases
- Life expectancy less than 3 months
- Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic instruments or other metal materials
- Coagulopathy with platelet count less than 50000
- Active infectious disease
- Age below 18 years
- Pregnancy of breastfeeding
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00922181
Start Date
August 1 2008
End Date
April 1 2009
Last Update
November 16 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Gasthuisberg
Leuven, Vlaams-Brabant, Belgium, 3000